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Abstract
Background: Co-existence of  metabolic syndrome (MetS) and electrocardiography (ECG) abnormalities heightens the risk of  
sudden cardiac death.  However, there is a gap in evidence of  how ECG changes cluster among continental Africans with or 
without MetS.
Methods: We included 491 participants with interpretable ECG tracings who were consecutively recruited into the Cardio-
vascular Risk Prediction Registry (CRP). CRP is a registry of  newly presenting patients into cardiology clinic of  the University 
College Hospital, Nigeria, with a main objective of  cardiovascular risk stratification to prevent cardiovascular morbidity and 
mortality. Using the International Diabetic Federation (IDF) criteria they were divided into those with metabolic syndrome and 
non-metabolic syndrome.
Results: Four hundred and ninety-one participants comprising 48.3% women with mean age 53.72±15.2 years who met the 
IDF criteria with complete ECG interpretations were analyzed with 44.2% (men 38.6%; women 50.2%) of  the participants hav-
ing MetS while 74% had ECG abnormalities. Compared to women, men had higher mean serum total cholesterol, creatinine, 
smoking, and alcohol use, family history of  hypertension and diabetes mellitus, QT prolongation, LVH plus or minus strain 
pattern, and ECG abnormalities in general. Women were heavier, had higher heart rate and proportions of  MetS. ECG findings 
among those with or without MetS were not significantly different. In men, IDF metabolic score was associated with conduc-
tion abnormalities (p=0.039) and combined ECG abnormality (p=0.042) which became more significant with an exclusion of  
QT prolongation (p=0.004). Also, IDF abdominal obesity was associated with QT prolongation (p=0.017), combined ECG 
abnormality (p=0.034) while HDLc correlated with ECG abnormalities (0.037) in men.  There was no significant associations 
of  components of  metabolic syndrome with ECG abnormalities among women.
Conclusion: There was a high prevalence of  MetS and abnormal ECG among the studied population. Abnormal ECG findings 
were more common in men with no differential association in people with or without MetS. However, a significant association 
existed between certain components of  MetS and ECG abnormalities in men only. Male gender and HDLc were independent 
predictors of  ECG Abnormalities.
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Introduction
Metabolic syndrome (MetS) is a constellation of  car-
dio-metabolic risk factors that contribute immensely to 
the burden of  cardiovascular morbidity and mortality 
worldwide. The prevalence of  MetS varies depending 
on the diagnostic criteria and study populations1-3. Due 
to epidemiologic transitions arising mainly from an un-
healthy lifestyle, the incidence of  MetS is on a steady rise 
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License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.   
African 
Health Sciences
African Health Sciences Vol 19 Issue 4, December, 2019 2829
in low and middle-income countries (LMICs), as well as 
high-income countries (HICs).  Prevalence as much as 
40% has been reported in some HICs, while in Nigeria it 
has been found to be about 30%4,5. This burden is expect-
ed to increase in near future with it attendant high risk of  
cardiovascular disabilities and sudden deaths6,7.
Metabolic syndrome has been associated with sudden 
cardiac death(SCD).8 In ARIC (Atherosclerosis Risk in 
Communities) Study, compared with participants without 
MetS, those with metabolic syndrome independent of  
race and ethnicity, had approximately 70% increased the 
risk of  sudden cardiac death. Elevated blood pressure, 
impaired fasting glucose and low -density lipoprotein 
cholesterol as Mets components were shown to be the 
independent determinants of  SCD.9
Interestingly, each of  the components of  MetS such as 
dyslipidemia, elevated blood pressure, insulin resistance 
± glucose intolerance,  as well as abdominal obesity has 
been shown to cause cardiac structural damages and ar-
rhythmias10-13. Coexistence, therefore of  MetS and ECG 
abnormalities may increase the risk of  sudden cardiac 
death. However, there is a paucity of  data on the associ-
ation of  cardiac arrhythmias and metabolic syndrome.14 
Early detection of  these cardiac abnormalities using base-
line 12 –lead ECG which is simple, noninvasive and cost 
-effective can help identify at-risk individuals for prompt 
and focused management. 
Studies differ on the prevalence and associations of  com-
ponents of  MetS with ECG abnormalities. In certain 
populations, a high prevalence of  ECG abnormalities in 
metabolic syndrome were reported10,15-18. While coronary 
artery disease and its attendant ECG changes have similar 
findings among Caucasians, and same are rarely reported 
among Africans19,20. Despite the huge burden of  stroke, 
heart failure and kidney failure in sub-Sahara Africa 
(SSA), data on ECG changes among metabolic syndrome 
patients alone are lacking. In order to address this gap and 
to show how ECG changes cluster among Africans with 
MetS, we report ECG changes in a Nigerian population 
with MetS compared to those without MetS.
Methods
Subjects and methods
This cross-sectional and comparative study was conduct-
ed over a period of  one year from July 2014 to June 2015 
following approval by the Joint University of  Ibadan (UI)/
University College Hospital (UCH) Ethics Committee 
approval reference number UI/EC/14/0136 dated 19th 
June 2014. Four hundred and ninety-one adult patients 
with complete data for the diagnosis of  metabolic syn-
drome and interpretable ECG tracings from CRP registry 
were studied.  Cardiovascular Risk Prediction (CRP) is a 
registry of  newly presenting patients into the cardiology 
division, medical out-patient department of  University 
College Hospital Ibadan. The main aim of  the registry is 
to risk stratify the patients at entry using Framingham and 
QRISK2  cardiovascular risk score for prompt manage-
ment of  at-risk individuals to prevent future cardiovascu-
lar morbidity and mortality.
Biodata of  the participants was obtained using pretested 
questionnaires containing information on demographics, 
family history of  cardiovascular diseases, life-styles and 
medication history. The contact information of  the par-
ticipants and their next of  kin were obtained for commu-
nication during follow-up.
Assessment of  anthropometric measurement
Anthropometric measurements including height, weight, 
waist and arm circumferences were obtained by trained 
nurses at the medical outpatient clinic. Height was mea-
sured without shoes to the nearest centimeter using a 
ruler attached to the wall. Weight was measured to the 
nearest 0.1kg on an electronic scale, with the subject 
wearing light outdoor clothing. Waist circumference was 
measured at the end of  expiration at a mid-way between 
the rib cage and the iliac crest using an anthropometric 
measuring tape. Average of  three measured waist circum-
ferences, recorded to the nearest tenth of  a centimeter 
was obtained for analysis.
Obesity was classified based on BMI in kg/m2 as nor-
mal (>20 and <25), overweight (>25 and <30), obesity 
(>30 and <35) and severe obesity (≥35)21. Abdominal 
obesity was defined based on the International Diabet-
ic Federation (IDF) criteria using waist circumference 
(≥94cm (men), ≥80cm (female). Participants were fur-
ther categorized as normal risk (men <94cm; women 
<80 cm), increased risk (men 94-102cm; women 80–88 
cm), or substantially increased risk (men >102cm; women 
>88 cm) on the basis of  the World Health Organization’s 
standards for increased health risk associated with waist 
circumference22,23.
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Assessment of  blood pressure
The clinic blood pressure was measured in a relaxed sit-
ting position using a standard Omron (HEM711DLX) 
with blood pressure apparatus on the left arm, placed at 
heart level after 5-minute rest and using a cuff  of  appro-
priate size with legs uncrossed. Three BP measurements 
were obtained with a minimum interval of  one minute 
and average of  the last two measurements was used in 
the present analysis. Hypertension was defined as systol-
ic blood pressure (SBP) ≥ 140mmHg and/or diastolic 
blood pressure (DBP) ≥ 90mmHg or being on antihyper-
tensive  treatment.
Electrocardiography
All participants for this study had resting 12-lead ECG, 
using a commercially available CONTEC® Workstation 
Model CONTEC EC8000G, ECG machine (Made in 
China) at speed of  25mm/s and 1mV/cm calibration. 
The entire ECG tracing used were inspected visually by 
the blinded ECG technicians in our non-invasive cardi-
ology laboratory to detect technical errors, unrecorded 
leads and inadequate quality of  tracings. Defective ones 
are repeated before data was extracted for use in the study.
The ECG tracings were independently analyzed by the 
cardiologists who were unaware of  the details of  the 
clinical status of  the patients. Abnormalities obtained 
from the ECGs were defined according to standard cri-
teria24,25 (table 1). Left ventricular hypertrophy was di-
agnosed using the following criteria: Sokolow-Lyon volt-
age (sum of  the amplitudes of  S wave in V1 and R wave 
in V5 or V6 ≥3.5 mV). Repolarization abnormalities in 
leads V5 and/or V6 indicated typical strain when there 
was down-sloping convex ST segment with an inverted 
asymmetrical T-wave opposite to the QRS axis26,27. QT 
interval was determined using the tangent method28. 
The measured QT interval was corrected for heart rate 
using the Bazett’s formula.  Prolonged QT interval was 
considered present when the QTc was >450 milliseconds 
and >440milliseconds in women and men respectively. 
Presence of  other ST-T changes was documented ac-
cording to standard criteria24.
Table 1: Definitions of ECG Variables 
 
ECG Variables Definitions 
Atrial fibrillation(Afib) Coarse fibrillatory waves, irregular QRS, rate 400-
500beats per minutes 
Atrial flutter(Afl) Rate between 250 to 350 beats per minute, saw tooth 
pattern P waves 
Sinus arrhythmia Variation of the P-P interval, from one beat to the next, of 
at least 0.12 seconds, or 120 milliseconds 
Premature Ventricular 
Contraction(PVC) 
Abnormal QRS shape and QRS=≥120ms 
Premature Supra 
ventricular 
contraction(PSVC) 
Presence of sinus tachycardia, atrial tachycardia, atrial 
fibrillation, AVNRT complexes,  atrial flutter, multifocal 
atrial tachycardia, accelerated junctional tachycardia 
Left atrial 
enlargement(LAE) 
P wave in lead II is greater than ≥  120ms 
Bi-atrial enlargement(BAE) P wave in lead II is greater than 120ms and higher than 
≥  2.5mm 
Left Ventricular 
hypertrophy(LVH)Sokolow-
Lyon 
SV-I + RV-5 or RV-6 = ≥35 mm (whether male or female) 
Left Ventricular 
hypertrophy with strain 
SV-I + RV-5 or RV-6 = ≥35 mm (whether male or female) 
with T waves changes 
Right Ventricular 
hypertrophy(RVH) 
R/S ratio of greater than 1 in lead V1 in the absence of 
other causes or if the R wave in lead V1 is greater than 7 
millimeters tall 
P duration ≤0.120seconds 
QRS duration 0.80-0.120seconds 
PR interval 0.12-0.20seconds 
QT Interval 0.40 seconds( for males) and 0.44 seconds (for females) 
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Definition of  metabolic syndrome
Metabolic syndrome was defined based on International 
Diabetic Federation (IDF) criteria using waist circumfer-
ence (≥94cm (men), ≥80cm (female), or two or more of  
the following. i) Fasting triglyceride >150g/dL or specif-
ic treatment for this lipid abnormality. ii) HDL choles-
terol < 40mg/dL(men), <50mg/dL(women) or specific 
treatment for this lipid abnormality.  iii) Blood pressure 
>130mmHg (systolic), >90mmHg (diastolic) or on an-
ti-hypertensive treatment. iv)fasting plasma glucose ≥100 
mg/dL or previously diagnosed diabetes mellitus.29
Data management and statistical analysis
The data was analyzed using Statistical Package for So-
cial Sciences (SPSS), version 20.0 (IBM). The qualitative 
data were summarized as frequency and percentage while 
quantitative variables was summarized as means and stan-
dard deviations (SD). To investigate the statistical signifi-
cance of  the difference in continuous variables according 
to gender and the presence of  metabolic syndrome or 
not, independent samples t-test was employed. For cat-
egorical variables, the Chi-square test for the compari-
son of  proportions was employed. Association between 
selected demographic, clinical characteristics and ECG 
findings was investigated at bivariate and multivariate lev-
els with p-value <0.05.
Results
Four hundred and ninety-one participants comprising 
48.3% women with mean age 53.72±15.2 years who met 
the IDF criteria with complete ECG interpretations were 
analyzed.  44.2% (men 38.6%; women 50.2%) and 74% 
of  the participants had MetS and ECG abnormalities re-
spectively. As shown in Table 2 and 3, mean age, blood 
pressure parameters and waist circumference were com-
parable across gender. Compared to women, men had 
higher mean total cholesterol, creatinine, smoking, and al-
cohol use, and diabetes mellitus, QT prolongation, LVH 
plus or minus strain pattern, and ECG abnormalities in 
general. Women were heavier, had higher heart rate and 
proportions of  MetS. Expectedly, participants with MetS 
compared with those without MetS had higher mean 
blood pressure, waist circumference, BMI, Triglyceride, 
fasting plasma glucose and smoking history. ECG find-
ings were similar among the group.  
           Table 2. Characteristics of Study Participant by Gender 
 
Variables Total 
491 (100%) 
Male 
254 
(51.7%) 
Female 
237 
(48.3%) 
p-
Value 
Age (years) 53.72±15.2 54.37±15.5 53.03±14.8 0.328 
Alcohol Use (%) 130 (26.5) 90 (35.4) 40 (16.9) <0.0001 
Ex-Smoker (%) 114 (23.2) 82 (32.3) 32 (13.5) <0.0001 
Current Smoker (%) 3 (0.6) 3 (1.2) 0 (0.0) 
Hip Circumference (cm) 102.13±14.7 99.68±13.6 104.77±15.5 <0.0001 
Waist Circumference (cm) 93.09±14.8 91.97±15.6 94.30±13.8 0.081 
Body Mass Index (Kg/m2) 27.34±5.8 25.80±4.9 28.98±6.1 <0.0001 
Systolic Blood Pressure (mmHg) 144.53±24.4 145.33±24.0 143.65±24.8 0.449 
Diastolic Blood Pressure (mmHg) 89.13±16.5 89.75±17.1 88.44±15.8 0.381 
Fasting Blood Sugar (mg/dL) 98.97±36.0 102.02±41.1 95.71±29.4 0.069 
Urea (mg/dL) 28.30±17.6 30.28±21.0 26.26±12.8 0.013 
Creatinine (mg/dL) 1.31±1.1 1.25±0.8 1.01±1.3 0.014 
Total Cholesterol (mg/dL) 185.28±45.6 180.14±46.4 190.98±44.0 0.011 
Triglyceride (mg/dL) 100.99±39.4 102.90±45.1 98.89±32.0 0.275 
Low Density Lipoprotein Cholesterol 
(mg/dL) 
117.15±38.2 114.07±37.8 120.55±38.4 0.069 
High Density Lipoprotein (mg/dL) 47.18±17.34 44.94±16.0 49.66±18.4 0.003 
ECG Changes 
Heart Rate (beat/minute) 84.01±18.3 81.74±17.5 86.38±19.0 0.008 
P Duration (ms) 113.10±31.2 111.94±30.1 114.23±32.3 0.445 
QRS Duration (ms) 113.64±30.8 115.51±30.1 111.71±31.4 0.197 
T Duration (ms) 266.04±44.0 266.41±42.2 265.68±45.8 0.890 
PR Interval (ms) 151.38±35.7 150.10±33.7 152.63±37.5 0.471 
QT Interval (ms) 405.43±48.7 405.32±46.0 405.54±51.5 0.963 
QTc Interval (ms) 475.71± 
70.5 
469.46±71.3 482.13±69.3 0.061 
LVH (%) 153 (32.7) 92 (38.2) 61 (26.9) 0.009 
LVH with Strain Pattern (%) 44 (9.5) 34 (14.4) 10 (4.4) <0.0001 
Prolonged QT (%) 269 (58.0) 150 (62.8) 119 (52.9) 0.031 
ECG Abnormalities (%) 356 (74.0) 199 (79.9) 157 (67.7) 0.002 
Diabetes Mellitus (%) 35 (8.1) 25 (11.2) 10 (4.8) 0.014 
MetS (%) 217 (44.2) 98 (38.6) 119 (50.2) 0.010 
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Tables 4, 5 and 6 depict gender differences in ECG chang-
es and Components of  MetS. In men IDF metabolic score 
was associated with conduction abnormalities (p=0.039) 
and combined ECG abnormality (p=0.042) which be-
came more significant with the exclusion of  QT prolon-
gation (p=0.004). Also, IDF abdominal obesity was asso-
ciated with QT prolongation (p=0.017), combined ECG 
abnormality (p=0.034), and HDLc with ECG abnormal-
ities (0.037).  No significant associations of  components 
of  metabolic syndrome with ECG abnormalities among 
women. Table 7 shows that male gender and HDLc were 
independent predictors of  ECG Abnormalities. 
  
Table 3: Basic Demographic and Clinical Parameters versus Metabolic Syndrome 
 
Variables Total 
491 (100%) 
Non-Metabolic 
Syndrome 
(NMetS) 
274 (55.8%) 
Metabolic 
Syndrome 
(MetS) 
217 (44.2%) 
p-Value 
Age (years) 53.72±15.2 53.06±16.7 54.57±13.0 0.262 
Alcohol Use (%) 130 (26.5)  72 (26.3) 58 (26.7) 0.430 
Smoking Status Former Smoker (%) 114 (23.2) 76 (27.7) 38 (17.5) 0.030 
Current Smoker (%) 3 (0.6) 0 (0.0) 3 (1.4)  
Occupation Professional (%) 138 (28.1) 65 (23.7) 73 (33.6) 0.001 
Unskilled (%) 4 (0.8) 2 (0.7) 2 (0.9)  
Hip Circumference (cm) 102.13±14.7 97.28±14.7 108.26±12.3 <0.0001 
Waist Circumference (cm) 93.09±14.8 87.24±13.8 100.48±12.5 <0.0001 
Hip Waist Ratio 6.00±65.4 9.12±88.1 2.36±15.2 0.418 
Body Mass Index (Kg/m2) 27.34±5.8 25.31±5.3 29.93±5.3 <0.0001 
Waist Height Ratio 0.58±0.3 0.54±0.2 0.63±0.4 <0.0001 
Waist Hip Ratio 0.93±0.4 0.92±0.5 0.93±0.1 0.787 
Systolic Blood Pressure 
(mmHg) 
144.53±24.4 139.57±24.7 150.69±22.5 <0.0001 
Diastolic Blood Pressure 
(mmHg) 
89.13±16.5 86.50±16.7 92.39±15.6 <0.0001 
Fasting Blood Glucose (mg/dL) 98.97±36.0 94.72±37.5 103.94±33.7 0.008 
Urea (mg/dL) 28.30±17.6 28.92±21.2 27.55±11.5 0.401 
Two Hours Fasting Blood 
Sugar (mg/dL) 
121.06±55.0 111.82±49.2 130.55±59.0 0.010 
Creatinine (mg/dL) 1.13±1.1 1.121±0.8 1.14±1.39 0.821 
Total Cholesterol (mg/dL) 185.28±45.6 184.85±46.5 185.76±44.6 0.831 
Triglyceride (mg/dL) 100.99±39.4 93.54±35.0 109.45±42.4 <0.0001 
Low Density 
Cholesterol (mg/dL) 
117.15±38.2 115.49±38.5 119.03±37.8 0.320 
High Density Lipoprotein (mg/
dL) 
47.18±17.3 50.95±19.0 42.94±14.1 <0.0001 
  
 Table 4:   Comparisons of ECG abnormalities in metabolic syndrome 
Variables Total 
491 (100%) 
Non-Metabolic Syndrome 
274 (55.8%) 
Metabolic Syndrome 
217 (44.2%) 
p-
Value 
P Duration (ms) 113.10±31.2 111.77±33.5 114.61±28.4 0.356 
QRS Duration (ms) 113.64±30.8 115.04±32.6 112.02±28.5 0.306 
T Duration (ms) 266.04±44.0 267.63±47.6 264.19±39.5 0.515 
PR Interval (ms) 151.38±35.7 151.23±37.1 151.55±34.1 0.927 
QT Interval (ms) 405.43±48.7 407.18±51.3 403.42±45.6 0.423 
QTc Interval (ms) 475.71± 70.5 479.64± 79.9 471.20±57.9 0.203 
Left Atrial Enlargement (%) 47 (9.6) 28 (10.2) 19 (8.8) 0.787 
Bi-Atrial Enlargement (%) 11 (2.2) 7 (2.6) 4 (1.8) 0.789 
LVH (%) 153 (31.2) 93 (33.9) 60 (27.6) 0.324 
LV Strain Pattern (%)  44 (9.0) 26 (9.5) 18 (8.3) 0.885 
RV Hypertrophy (%) 12 (2.4) 9 (3.3) 3 (1.4) 0.385 
Prolonged QT interval (%) 269 (58) 146 (57.6) 123 (58.6) 0.85 
ECG Abnormalities (%) 356 (74.0) 200 (74.3) 156 (73.6) 0.917 
ECG Abnormalities {Without 
QT Abnormality} (%) 
255 (53.6) 152 (57.4) 103 (48.8) 0.065 
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   Table 5.  Gender specific characteristics in metabolic syndrome 
Variables Male p-Value Female p-Value 
Non-
Metabolic 
Metabolic 
 
Non-
Metabolic 
Metabolic 
 
Age (years) 53.34±17.1 56.03±12.6 0.181 52.68±16.2 53.36±13.2 0.724 
Body Mass Index (kg/m2) 23.87±4.3 28.93±4.2 <0.0001 27.22±5.9 30.73±5.9 <0.0001 
Hip Circumference (cm) 94.67±12.9 107.65±10.7 <0.0001 100.74±16.3 108.76±13.5 <0.0001 
Waist Circumference 
(cm) 
84.81±12.5 103.37±12.9 <0.0001 90.45±14.8 98.11±11.9 <0.0001 
Systolic Blood Pressure 
(mmHg) 
140.94±24.1 152.29±22.3 <0.0001 137.73±25.5 149.38±22.7 <0.0001 
Diastolic Blood Pressure 
(mmHg) 
87.58±16.6 93.19±17.4 0.011 85.04±16.8 91.73±14.1 0.001 
Fasting Blood Sugar 
(mg/dL) 
98.03±46.0 108.25±31.3 0.070 90.07±19.6 100.59±35.1 0.010 
Urea (mg/dL) 30.71±25.2 29.63±12.3 0.700 26.68±14.7 25.84±10.6 0.620 
Creatinine (mg/dL) 1.28±0.9 1.22±0.4 0.546 0.93±0.4 1.09±1.8 0.362 
Total Cholesterol 
(mg/dL) 
176.23±45.8 185.89±46.9 0.112 197.15±44.8 185.66±42.8 0.054 
Triglyceride (mg/dL) 94.97±38.1 114.56±51.9 0.001 91.50±30.1 105.20±32.3 0.001 
Low Density Cholesterol 
(mg/dL) 
111.67±36.5 117.59±39.5 0.232 120.93±40.7 120.23±36.5 0.893 
High Density Lipoprotein 
(mg/dL) 
46.92±15.4 42.05±16.7 0.020 56.65±22.1 43.67±11.6 <0.0001 
Heart Rate 
(beats/minutes) 
83.26±17.7 79.57±17.0 0.120 86.35±18.9 86.41±19.1 0.982 
P Duration (ms) 112.01±33.7 111.84±24.3 0.968 111.49±33.4 116.81±31.2 0.233 
QRS Duration (ms) 113.85±32.2 117.85±26.9 0.332 116.53±33.2 107.19±28.9 0.029 
T Duration (ms) 267.62±42.9 264.85±41.6 0.704 267.64±2.5 263.63±37.9 0.602 
PR Interval (ms) 151.26±35.4 148.52±31.4 0.566 151.19±39.1 153.99±36.1 0.590 
QT Interval (ms) 404.36±49.8 406.67±40.2 0.713 410.67±53.1 400.73±49.7 0.158 
QTc Interval (ms) 471.51±78.6 466.59±59.9 0.614 489.71±80.7 475.02±56.1 0.121 
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Discussion
In this study, approximately 4 out of  10 participants had 
MetS while three quarters had ECG abnormalities. Ab-
normal ECG findings were commoner in men with no 
differential association in people with MetS and those 
without MetS. However, a significant association existed 
between certain components of  MetS and ECG abnor-
malities in men only. 
The prevalence of  44.2% in this current study is almost 
twice the prevalence earlier reported by our team among 
the health workers. While women had excess MetS in 
both study cohorts, the gaps appear closing up among 
the gender, “34.9% vs 2.4% among health workers as 
against 50.2% vs 38.6%.’’30. Similarly, our finding of  a 
high proportion of  MetS was higher than others reported 
in Nigerian communities31. The rising trends may not be 
unconnected with  equally increasing components such 
as obesity, hypertension, dyslipidemias and insulin resis-
tance resulting from unhealthy lifestyles and epidemio-
logic transition32. May also be due to the fact that it was 
prevalence at a referral clinic.
 Contrary to our findings, probably due to the influence 
of  wealth and intake of  atherogenic diets, Barrios and 
colleagues in Spain,33 Ford and colleagues34 in the United 
States, and Yassein and colleagues35 in Jordan reported 
higher prevalence rates of  52%, 62.9%, and 52%, respec-
tively. With a high proportion of  metabolic syndrome 
components (high BP, 80.7%; central obesity, 67%; low 
HDL, 68.7% and hyperglycemia, 30%) in this cohort, 
MetS incidences will soon rival those of  HICs.  Apparent-
ly, our study population requires urgent care to prevent a 
possible escalation of  stroke, heart failure, and Myocar-
dial infarction associated with increasing prevalence of  
MetS. 
 
Table 6.  Gender specific association between components of metabolic syndrome  
and ECG Abnormality 
 
Variables Male p-Value Female p-Value 
ECG-
Abnormality 
No ECG-
Abnormality  
ECG-
Abnormality 
No ECG-
Abnormalit
y 
 
IDF-
Abdominal Obesity (%) 
101 (50.8) 17 (34.0) 0.034 135 (86.0) 69 (92.0) 0.189 
IDF-Blood Pressure (%) 170 (81.3) 39 (78.0) 0.173 122 (78.2) 55 (75.3) 0.630 
IDF-Glucose (%) 64 (36.8) 12 (26.1) 0.175 37 (26.8) 15 (28.8) 0.460 
IDF-Triglceride (%) 21 (11.0) 5 (10.4) 0.908 9 (6.3) 6 (8.6) 0.533 
IDF-HDLc (%) 134 (70.5) 41 (85.4) 0.037 87 (60.4) 47 (67.1) 0.340 
  
Table 7: Determinants of ECG abnormalities in the study population 
 
 Variable Odd ratio 95% Confidence Interval P value 
Age 1.006 0.990 - 1.022 0.460 
Male Gender 1.904 1.126 - 3.220 0.016 
IDF_Abdominal Obesity 0.944 0.540 - 1.651 0.839 
MS_Blood Glucose 0.825 0.490 - 1.389 0.469 
MS_Blood Pressure 0.837 0.461 - 1.519 0.558 
MS_High Density Lipoprotein 1.843 1.068 - 3.180 0.028 
MS_Triglyceride 1.172 0.517 - 2.661 0.704 
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Abnormalities in resting electrocardiograph (ECG) have 
been strongly associated with cardiovascular morbidity 
and mortality.36 Its coexistence with MetS potentiates the 
rate of  sudden cardiac deaths.37  In this study, we report a 
high prevalence of  ECG abnormalities and MetS. There 
was no association between MetS and ECG abnormali-
ties. However, central obesity and low HDL were signifi-
cantly associated with ECG abnormalities in men. Similar 
to our findings, Ebong et.al in MESA study reported a 
high prevalence of  ECG in Mets which were gender spe-
cific38. However, they found associations between ECG 
abnormalities and MetS and its components; high blood 
pressure and triglyceride.  The reasons for these discrep-
ancies were not immediately obvious. Our finding, show-
ing no association between ECG changes and MetS is 
similar to an earlier study in Nigeria17. Apart from the 
larger population in our study, gender-specific association 
between components of  MetS and ECG abnormalities 
was not explored, which our study showed.
Similarly, a study in African Americans which share an-
cestry with blacks in sub-Saharan Africans showed high 
a proportion of  ECG changes among their study popu-
lation, so also among Caucasians16,39,40. Our study specif-
ically showed a high prevalence of  prolonged QTc, left 
ventricular hypertrophy (LVH) and LVH with strains ab-
normality similar to other studies16. This is not surprising 
since studies have shown high preponderance of  LVH 
among blacks.41,42. Left ventricular hypertrophy is an in-
dependent risk factor for stroke. Prolongation of  the QT 
and QTc intervals is caused by the heightened sympa-
thetic activity characteristic of  obesity that increases the 
reduced heart rate variability; all these elements have the 
potential to cause arrhythmia and may lead to cardio-em-
bolic stroke.
Previous studies have established the role of  uncontrolled 
elevated blood pressure and other traditional cardiovas-
cular risk factors in structural myocardial changes which 
are interpreted from ECG recordings43. The aggregates 
of  these risk factors which constitutes MetS are suspect-
ed to produce more abnormal ECG changes in people 
with MetS compared with those without MetS. Our study 
did not have significant changes between the two groups. 
However, certain components of  MetS were significantly 
different among men only.  High frequency of  hyperten-
sion among the groups may account for the insignificant 
ECG findings. 
The implication of  our findings to clinical care is that 
people referred for cardiac care in our center who have 
high aggregates of  cardiovascular risk factors should have 
an ECG done at presentation. This is because of  the high 
prevalence of  significant abnormalities which may be due 
to high prevalence of  hypertension and dyslipidemia, 
the most important drivers of  ECG changes, especially 
among blacks.17,44,45
Strengths and limitation
Our study has several strengths; one of  such is estab-
lishing the burden of  metabolic syndrome and abnormal 
ECG among the first timer at a cardiac clinic in Nigeria. 
Our findings have implications for early risk stratification 
of  our patients for prompt management. However, the 
cross-sectional study design is a limitation, as the caus-
al relationship cannot be established. Also the use of  
Sokolow Lyon criteria which is non sex-specific might 
have exaggerated our findings of  LVH in men. In addi-
tion, the small sample size and hospital-based data collec-
tion limit the generalization of  our findings to the general 
population.
Conclusion
MetS and abnormal ECG changes are common among 
the studied population. While women had a higher prev-
alence of  MetS, men had more abnormal ECG findings 
with a significant association between abdominal obesity, 
dyslipidemia and ECG abnormalities in men only. Larger 
prospective study is required to support gender - specific 
cardiac care in this population.
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